NEUROCRINE BIOSCIENCES INC
Public company- Headquarters
- SAN DIEGO, California
- Industry
- Biotechnology
- Ticker
- NBIX
- CIK
- 0000914475
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOEiry W. Roberts, M.D. | Sep 28, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Executive appointment
CMO appointed: Eiry W. Roberts, M.D.
Eiry W. Roberts, M.D. was named Chief Medical Officer of NEUROCRINE BIOSCIENCES INC, effective September 28, 2026. Eiry W. Roberts, M.D. succeeds Sanjay Keswani, M.D.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 28, 2026Role: Chief Medical Officer
- Executive departure
CMO departs: Sanjay Keswani, M.D.
Sanjay Keswani, M.D., Chief Medical Officer of NEUROCRINE BIOSCIENCES INC, leaves the role, effective September 25, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 28, 2026Role: Chief Medical Officer
Last verified Nov 8, 2026